Is PSG.DE stock a buy after the intraday pullback?

PSG.DE stock shows a tactical oversold bounce setup but not a buy-and-hold signal. Use small position sizing, a stop around **€28.10**, and target **€31.00**. Review valuation and Meyka AI’s fair value **€27.36** before longer holds.

What are the main risks for PSG.DE stock traders?

Key risks for PSG.DE stock include slow inventory turnover (**400.36** days), OTC demand swings, and a relatively high price-to-book **9.12**. These can turn a short-term bounce into a failed move if sector flows reverse.

How does Meyka AI rate PSG.DE stock and what does it mean?

Meyka AI rates PSG.DE with a score **78.99/100** (Grade B+, Suggestion: BUY). The grade combines benchmark, sector, growth, metrics and forecasts; it informs tactical bias but is not investment advice.

What price targets should traders use for PSG.DE stock?

For PSG.DE stock use a near-term intraday target **€31.00**, a conservative 12-month fair value **€27.36** from Meyka AI, and a 5-year projection **€31.56**. Adjust targets to risk tolerance and news flow.

DE Stocks

PSG.DE PharmaSGP XETRA €29.00 intraday 24 Feb 2026: Oversold bounce trade idea

ByHuzaifa Zahoor February 24, 2026

PSG.DE stock trades at €29.00 on XETRA intraday on 24 Feb 2026 and shows a clear oversold bounce setup after a shallow pullback. Volume today is 12,424.00 shares, about 2.30x the average, which supports a short-term mean-reversion move. The balance of fundamentals and tight liquidity makes PharmaSGP Holding SE a candidate for a tactical rebound trade in Germany’s healthcare group. We outline the technical trigger, valuation context, Meyka AI grade and a disciplined trade plan.